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Themicrotubule-associated protein tau accumulates
in Alzheimer’s and other fatal dementias, which
manifest when forebrain neurons die. Recent ad-
vances in understanding these disorders indicate
that brain dysfunction precedes neurodegeneration,
but the role of tau is unclear. Here, we show that early
tau-related deficits develop not from the loss of
synapses or neurons, but rather as a result of
synaptic abnormalities caused by the accumulation
of hyperphosphorylated tau within intact dendritic
spines, where it disrupts synaptic function by im-
pairing glutamate receptor trafficking or synaptic
anchoring. Mutagenesis of 14 disease-associated
serine and threonine amino acid residues to create
pseudohyperphosphorylated tau caused tau misloc-
alization while creation of phosphorylation-deficient
tau blocked the mistargeting of tau to dendritic
spines. Thus, tau phosphorylation plays a critical
role in mediating tau mislocalization and subsequent
synaptic impairment. These data establish that the
locus of early synaptic malfunction caused by tau
resides in dendritic spines.
INTRODUCTION
Neurofibrillary tangles, themost common intraneuronal inclusion
and a cardinal feature of Alzheimer’s disease (AD), appear when
tau forms insoluble aggregates (reviewed in Avila et al., 2004;
Gendron and Petrucelli, 2009). Once believed to mediate
neuronal death and cognitive deficits, observations in mouse
models have since shown that tangles exert negligible neurotox-
icity compared to soluble tau (Santacruz et al., 2005; Oddo et al.,
2006). However, it is unclear how soluble tau disrupts brain func-
tion. Healthy neurons maintain a spatial gradient of tau, whoseNeconcentration is greater in axons than in somatodendritic
compartments (Papasozomenos and Binder, 1987; for review,
see Bue´e et al., 2000; Avila et al., 2004). In neurological disor-
ders, such as AD, the gradient becomes inverted (reviewed in
Bue´e et al., 2000; Brandt et al., 2005; Gendron and Petrucelli,
2009), potentially disrupting kinesin and dynein motor protein
function and axonal transport (Mandelkow et al., 2003; Dixit
et al., 2008), permitting direct neurotoxic interactions between
tau and the actin cytoskeleton (Fulga et al., 2007), or enabling
the accumulation of tau aggregates in the dendrites of neurons
damaged by severe axonal and synapse loss (Yoshiyama
et al., 2007). These hypotheses may explain how tau induces
neurodegeneration, which correlates well with symptoms (re-
viewed in Bue´e et al., 2000; Avila et al., 2004; Brandt et al.,
2005) but do not address how tau diminishes brain function at
the preclinical stages of disease immediately preceding neuro-
degeneration (Arvanitakis et al., 2007; Petrie et al., 2009). We
investigated how tau induces early memory deficits and disrupts
synaptic plasticity, prior to overt synaptic or neuronal degenera-
tion, using both in vivo and in vitro models.RESULTS
Cognitive Impairments and htau Mislocalization
in rTgP301L Mice
In the rTg4510 mouse model of tauopathy, which exhibits the
regulated expression of P301L human tau (htau) associated
with frontotemporal dementia with Parkinsonism linked to chro-
mosome 17 (FTDP-17), called rTgP301L here, we focused our
initial investigations upon mice at 1.3 and 4.5 months of age,
prior to the loss of synapses or neurons (Ramsden et al., 2005;
Santacruz et al., 2005) and found spatial memory deficits first
appearing in the older mice (Figure 1). Examination of spatial
reference memory with the Morris water maze (Westerman
et al., 2002) demonstrated cognitive impairments in 4.5, but
not 1.3, month-old rTgP301L mice (*p < 0.05 by repeated-
measures ANOVA; Figures 1A–1C). We found a direct corre-
spondence between deficits in spatial reference memory anduron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Inc. 1067
Figure 1. Memory and Synaptic Plasticity in
rTgP301L Mice
(A) Timeline of sequential training and testing in the
Morris water maze as previously described (West-
erman et al., 2002; Ramsden et al., 2005).
(B) No deficits were observed in locating the visible
platform at any age. Only 4.5-month-old rTgP301L
mice showed a significant deficit in learning to
locate the hidden platform.
(C) rTgP301L mice at 4.5 but not 1.3 months (M)
showed impaired retention of spatial reference
memory as assayed by the platform crossing
index. n = 12 rTg mice at each age and n =
4 mice for each TgNeg group at each age (B) for
a total of 12 mice for pooled TgNeg group (C).
(D) There was no difference in theta burst stimuli
(TBS)-induced long term potentiation (LTP) of field
excitatory postsynaptic potentials (fEPSPs) in the
CA1 hippocampal subfield between rTgP301L
and TgNeg littermates at 1.3 months.
(E) LTP was impaired in 4.5-month-old rTgP301L
mice. n = 10 brain slices from each group in 4.5-
month-old mice (n = 6 animals/genotype); n =
14 rTg brain slices and n = 12 control slices from
1.3-month old mice (n = 6 animals/genotype). +/+,
rTgP301L mice; +/, /+, or /, TgNeg control
mice that express the activator, responder, or
neither transgene, respectively. For experiments
in (C)–(E), the TgNeg control mice were combined
into one group designated as TgNeg since there
was no difference between TgNeg subpopulations
in cognitive performance (B). M, months; m,
meters. Repeated-measures ANOVA, *p < 0.05,
**p < 0.01.
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Specifically, long-term potentiation (LTP) in the CA1 hippo-
campal region was only impaired in 4.5-month old rTgP301L
mice (*p < 0.05 by repeated-measures ANOVA; Figures 1D and
1E), which suggested the possibility of postsynaptic abnormali-
ties. Taken together with the observation that htau interacts
directly with filamentous (F) actin (Fulga et al., 2007; He et al.,
2009), which concentrates in dendritic spines to a much greater
degree than in dendritic shafts (Fifkova´ and Delay, 1982; Hering
and Sheng, 2001), we tested the idea that in rTgP301L mice htau
mislocalizes to dendritic spines, the fundamental postsynaptic
units for information processing and memory storage in the
mammalian brain (Hering and Sheng, 2001). To control for the
possible effects of htau overexpression, we created rTg21221
mice, termed rTgWT here, expressing wild-type (WT) htau at
concentrations equivalent to P301L htau in rTgP301L mice.
Unlike rTgP301L mice, rTgWT mice show neither progressive
memory deficits nor neurodegeneration (**p < 0.01, ***p <
0.001, ****p < 0.0001 by repeated-measures ANOVA and
ANOVA; Figure 2 and see Figure S1 available online). We
prepared isolates from forebrain lysates of 4.5-month-old
rTgP301L, rTgWT, and transgenic negative (TgNeg) mice en-
riched in both pre- and postsynaptic proteins, termed the S2
fraction, and in postsynaptic density proteins, termed PSD-1
(Figure 3). We found equivalent levels of htau in the S2 fractions
of both transgenic mouse lines (Figures 3A and 3C) but signifi-
cantly higher htau levels in PSD-1 preparations from rTgP301L1068 Neuron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Incmice (*p < 0.05 by t test; Figures 3B and 3D). The lack of differ-
ences in PSD95 levels in PSD-1 preparations from TgNeg,
rTgWT and rTgP301L mice (p = 0.95 by ANOVA; Figure 3E)
indicated that the dendritic spines in rTgP301L mice remained
largely intact, despite the impairments of memory and synaptic
plasticity. As an additional control measure, we confirmed that
PSD95 levels did not change in relation to a-tubulin (p = 0.76
by ANOVA; Figure 3F). The association of abnormalities in
memory and synaptic plasticity with the presence of htau in
dendritic spines led us to hypothesize that htau mislocalization
to spines is an early pathological process that disrupts synaptic
function. We tested this hypothesis in vitro using cultured rat and
mouse neurons.
P301L htau Is Aberrantly Localized to Dendritic Spines
To visualize the cellular distribution of WT and P301L htau, we
transfected dissociated rat hippocampal neurons with plasmids
encoding GFP alone or cotransfected with plasmids encoding
DsRed protein and GFP-tagged htau, at 7–10 days in vitro
(DIV) and photographed the neurons 2 weeks later (Figures 4A,
4B, and S2). We found GFP-tagged htau in both axons and
dendrites (Figures 4A and 4B), in keeping with immunohisto-
chemical studies in monkey brain (Papasozomenos and Binder,
1987). Neurons expressing GFP alone and GFP-tagged htau
showed equivalent spine densities, consistent with observations
in transfected organotypic hippocampal slice cultures express-
ing htau (Shahani et al., 2006; p = 0.83 by ANOVA; black bars.
Figure 2. Lack of Age-Dependent Memory Deficits and Neurode-
generation in rTgWT Mice
(A) rTgWT mice were longitudinally tested in the Morris water maze and
compared to previously published data from the rTgP301L mice (Ramsden
et al., 2005) (2.5 M–9.5 M, n = 52 TgNeg, n = 17 rTgWT, and n = 9 rTgP301L).
rTgWT mice showed deficits in performance in the Morris water maze
compared to TgNeg mice. Deficits in rTgWT mice remained stable for several
months, while deficits in rTgP301L mice became more severe with increasing
age. Although rTgWT spent less time swimming in the target quadrant during
probe trials compared to TgNeg mice, only the rTgP301L mice exhibited an
age-related decline. Repeated-measures ANOVA data are as follows: trans-
gene: F(2,225) = 34.09, p < 0.0001; age versus transgene: F(6,225) = 3.61,
p < 0.01 ; age, TgNeg mice: F(3,153) = 0.345, p = 0.79; age, rTgWT mice:
F(3,48) = 1.518, p = 0.22; age, rTgP301L mice: F(3,24) = 5.82.
(B) While both rTgWT and rTgP301L mice exhibited a significant decrease in
whole brain weight early in life (1.3–4.5 months of age), suggestive of a devel-
opmental delay, the rTgP301L mice also exhibited neurodegeneration as evi-
denced by a progressive decrease in whole brain weight later in life
(7–10 months of age). Due to small sample numbers at some ages, mice
were binned into P1–P28, 1.3 M–4.5 M, and 7 M–10 M. Although there was
a trend toward decreased brain weights at P1–P28, this was not statistically
different. Data for transgene ANOVA are as follows: P1–P28: F(2,82) = 0.524,
p = 0.5939; 1.3 M–4.5 M: F(2,156) = 14.564, p < 0.0001; 7 M–10 M:
F(2,141) = 66.957, p < 0.0001. Sample sizes for TgNeg, rTgWT, rTgP301L,
respectively, are as follows: P1, n = 13, n = 2, n = 2; P7, n = 20, n = 3, n = 2;
P14, n = 17, n = 4, n = 4; P28, n = 9, n = 5, n = 4; 1.3 M, n = 18, n = 5,
n = 12; 3 M, n = 35, n = 15, n = 14; 4.5 M, n = 26, n = 21, n = 13; 7M, n = 19,
n = 14, n = 19; 9.5M, n = 12, n = 9, n = 12; 10M, n = 36, n = 9, n = 14.M,months;
**p < 0.01, ***p < 0.001, ****p < 0.0001.
See also Figure S1 for details on the creation and characterization of rTgWT
mice.
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Nein Figure 4C). Importantly, although WT htau rarely localized to
DsRed-labeled dendritic spines, P301L htau appeared in the
majority of the spines (Figures 4A and 4B).While the total number
of DsRed-labeled dendritic spines (‘‘all spines’’) was significantly
higher than tau-containing spines (‘‘spines with tau’’) in neurons
expressing WT or P301L htau (Figure 4C), significantly more
spines contained P301L thanWT htau (***p < 0.001 by Bonferroni
post hoc analysis; 31 ± 3 P301L htau-containing spines out of
42 ± 3 total spines versus 8 ± 2 WT htau-containing spines out
of 43 ± 4 total spines; Figure 4C), and the proportion of tau-con-
taining spines was significantly higher in neurons expressing
P301L htau (***p < 0.001 by t test; 75% ± 3% for P301L versus
23% ± 5% for WT htau; Figure 4D). These in vitro data corrobo-
rated our biochemical analyses of WT and P301L htau in post-
synaptic protein complexes in vivo (see Figure 3). Neither our
in vivo nor in vitro experiments examined the potential interac-
tions between htau and rodent tau.
Mislocalized htau Impairs Synaptic Function
To determine whether mislocalized htau affected dendritic spine
function, we recorded miniature excitatory postsynaptic
currents (mEPSCs) in mature (22–30 DIV) rat hippocampal
neurons expressing GFP alone or GFP-tagged htau (Figure 4E).
The majority of presynaptic inputs originated from untransfected
neurons, since virtually no GFP-fluorescent axons innervated
transfected neurons due to the minute proportion (<10%) of
neurons transfected with GFP-tagged htau. We thus attributed
any changes inmEPSCs to themodulation of postsynaptic activ-
ities by the htau in spines. LargemEPSCs (amplitude >20 pA; see
arrows in Figures 4E1 and 4E2) occurred more frequently in
neurons expressing GFP or WT htau than in neurons expressing
P301L htau (***p < 0.001 by Kolmogorov-Smirnov analysis for
P301L versus GFP; Figures 4E3 and 4F). P301L, but not WT,
htau significantly reduced the mean amplitude (***p < 0.001 by
Fisher’s PLSD post hoc analysis; Figure 4G) and frequency of
mEPSCs (***p < 0.001 by Fisher’s PLSD post hoc analysis Fig-
ure 4G) compared to GFP-transfected neurons.
We found similar P301L htau-mediated changes in the ampli-
tude (***p < 0.001 by Fisher’s PLSD post hoc analysis for P301L
versus rTgWT and TgNeg) and frequency (*p < 0.05 by Fisher’s
PLSD post hoc analysis for P301L versus rTgWT and TgNeg)
of mEPSCs in neurons cultured from rTgP301L mice, compared
to those cultured from rTgWT and TgNeg mice (Figures 5A–
5C). Because the P301L htau-mediated electrophysiological
changes in mouse neurons mimicked the effects seen in htau-
expressing rat neurons where the majority of presynaptic inputs
originated from untransfected neurons, we attributed the
changes in mEPSCs to the modulation of postsynaptic activities
by the htau in spines, suggesting that axonal tau contributed
minimally to the synaptic deficits in our in vitro experimental
system and indicating that P301L htau diminished synaptic func-
tion whether its expression originated from a genomic or an
extragenomic cistron. However, our results cannot exclude
possible presynaptic roles of tau in the pathological develop-
ment of neurodegenerative diseases. We noted that in both rat
and mouse neurons, the expression of WT htau caused a small
but significant decrease (*p < 0.05 by Kolmogorov-Smirnov
analysis for WT versus GFP [Figure 4F] or WT versus TgNeguron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Inc. 1069
Figure 3. Human Tau Levels in the Fore-
brains of rTgP301L and rTgWT Mice
(A) Tubulin and htau proteins in the S2 fraction of
forebrains from 4.5-month-old (4.5 M) TgNeg,
rTgWT, and rTgP301L mice.
(B) PSD95 and htau proteins in the PSD-1 fractions
of forebrains from the animals in (A).
(C) There was no difference in the normalized
levels of htau expression between rTgWT and
rTgP301L mice in the S2 fraction.
(D) There was more htau, normalized to PSD95, in
the PSD-1 fractions of rTgP301L mice.
(E) There was no difference in the levels of PSD95
between TgNeg, rTgWT, and rTgP301L mice.
(F) Levels of PSD95 did not change in relation to
a-tubulin between TgNeg, rTgWT, and rTgP301L
mice. n = 9–10 mice per group.
M,male; F, female. t test (CandD),ANOVA followed
by Bonferroni post hoc analysis (E), *p < 0.05.
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for rat and Figure 5B for mouse), suggesting that WT htau can
also impair synaptic function. Presumably, this is related to the
small amount of WT htau in spines (Figures 3B, 3D, 4C, and 4D).
Impaired Synaptic Function Is Associated with
Decreased Synaptic Expression of AMPA and NMDA
Receptors with No Visible Loss of Spines
The reduced amplitude of mEPSCs caused by P301L htau
suggests a reduction in the amount of functional AMPA recep-
tors (AMPARs) on the postsynaptic membrane, which has
been proposed to be a common mechanism underlying reduc-
tions in synaptic strength (Malinow andMalenka, 2002; Newpher
and Ehlers, 2008). The reduced frequency of mEPSCs, in the
absence of spine loss (Figures 3E and 4C), suggests either an
increase in the number of ‘‘silent synapses’’ or undetected
weak synapses due to loss of synaptic AMPARs (Liao et al.,
1995; Isaac et al., 1995). Therefore, we measured synaptic AM-
PARs. We labeled surface AMPARs in living neurons cultured
from TgNeg, rTgWT, and rTgP301L mice using a rabbit antibody
against the N terminus of glutamate receptor (GluR) type 1
subunits (N-GluR1) and labeled dendritic spines using a mouse
antibody against PSD95 (Figure 5D). We found distinct clusters
of AMPARs colocalizing with PSD95 in both TgNeg and rTgWT
neurons (denoted by arrows in upper panels in Figure 5D), but
not in rTgP301L neurons, in which weak N-GluR1 immunoreac-
tivity appeared along the dendritic shafts as diffuse staining
rather than distinct clusters (see triangles in the lower panels in
Figure 5D). Importantly, despite a significant reduction in the
fluorescence intensity of N-GluR1 colocalizing with PSD95
immunoreactivity in spines of rTgP301L neurons (***p < 0.001
by Fisher’s PLSD post hoc analysis; Figure 5E), the total number
of PSD95 clusters remained unchanged (Figure 5F), indicating
that the impairment of synaptic function caused by the accumu-1070 Neuron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Incb
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Since the stability and existence of
dendritic spines can be compromisedy the prolonged absence of functional synaptic AMPARs
cKinney et al., 1999; Richards et al., 2005; McKinney, 2010),
e loss of AMPARs reported here might be a cellular alteration
at leads to the previous observation that dendritic spines
egenerate in AD and in older mice modeling tauopathies,
cluding rTgP301L and P301S (Davies et al., 1987; Selkoe,
002; Hsieh et al., 2006; Eckermann et al., 2007; Yoshiyama
t al., 2007; Smith et al., 2009; Rocher et al., 2010; for review,
ee Knobloch and Mansuy, 2008).
To determine whether the decreased expression of synaptic
luR1 in rTgP301L neurons reflects a widespread tau-mediated
hibitory effect on synaptic glutamate receptor expression, we
lso examined levels of intracellular and synaptic GluR1,
luR2/3, and NMDA receptor (NMDAR) subunit 1A (NR1) in fixed
ouse cultures prepared from TgNeg, rTgWT and rTgP301L
ice (Figure 6). Immunocytochemical detection of glutamate
ceptors in fixed neurons provides a snapshot of receptor
luster localization at the time of fixation. We labeled total
luR1 and 2/3 receptors in fixed neurons cultured from TgNeg,
gWT, and rTgP301L mice using two different rabbit polyclonal
ntibodies against the C terminus of GluR1 or GluR2/3 subunits
iao et al., 1999) and labeled dendritic spines using a mouse
ntibody against PSD95 (Figures 6A and 6B). We found distinct
lusters of GluRs colocalizing with PSD95 in both TgNeg and
gWT neurons (denoted by small arrows in the upper panels
f Figures 6A and 6B), but not in rTgP301L neurons, in which
eakGluR immunoreactivity appeared along the dendritic shafts
s diffuse staining rather than distinct clusters (see large arrows
the lower panels of Figures 6A and 6B). Normalization of GluR1
nd GluR2/3 fluorescence intensity in spines to their respective
uorescence intensity in dendritic shafts demonstrated that the
ynaptic expression of GluR1 and GluR2/3 receptors are
ecreased in rTgP301L mice compared to TgNeg (***p < 0.001
y Fisher’s PLSD post hoc analysis; Figure 6D) and rTgWT
Figure 4. Effects of the FTDP-17-Linked
P301L Mutation on Tau Accumulation in
Dendritic Spines and Excitatory Synaptic
Transmission in Transfected Rat Neurons
(A) Overlaid images of living dissociated rat hippo-
campal neurons (21–28 DIV) coexpressing DsRed
and GFP-tagged htau proteins.
(B) Cropped images from (A) including DsRed,
GFP and overlaid images. Triangles denote
dendritic spines devoid of WT htau and arrows
denote spines containing P301L htau. See also
Figure S2 for unprocessed raw images of cultured
rat neurons cotransfected with DsRed and GFP-
WT htau or GFP-P301L htau.
(C) Quantification of total spines and htau-contain-
ing spines in neurons expressing GFP or coex-
pressing DsRed and GFP-tagged htau. There
was more htau in the dendritic spines of neurons
expressing P301L htau. n = 27 (GFP), 26 (WT),
and 25 (P301L) neurons per group.
(D) A higher percentage of spines contained htau
in neurons expressing P301L htau.
(E) Representative mEPSCs in neurons expressing
GFP (E1), GFP-tagged WT htau (E2), and GFP-
tagged P301L htau (E3). Large mEPSCs occurred
frequently in neurons expressing GFP or WT htau,
but rarely in neurons expressing P301L htau.
(F) Cumulative frequency distributions of mEPSC
amplitudes of the neurons in (E). There were mark-
edly more small mEPSCs in neurons expressing
P301L htau than those expressing GFP. There
was also a slight, but significant, decrease in the
proportion of large events in neurons expressing
WT htau (bin size = 1 pA).
(G) Mean mEPSC amplitudes and frequencies of
the neurons in (E). Neurons expressing P301L
htau exhibited smaller and fewer mEPSCs. n =
14 (GFP), 14 (WT), and 16 (P301L) neurons per
group.
ANOVA followed by Bonferroni (C) or Fisher’s
PLSD (G) post hoc analysis, t test (D), Kolmo-
gorov-Smirnov (F), *p < 0.05, **p < 0.01, ***p <
0.001.
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analysis; Figure 6D). As reported previously, (Liao et al., 1999),
synaptic GluR1 receptor expression detected on fixed neurons
(Figure 6A) strongly corresponded to surface N-GluR1 receptor
expression detected on living neurons (Figure 5D). Labeling of
total NR1 receptors with a rabbit polyclonal antibody against
the N terminus of NR1 (Liao et al., 1999) in fixed neurons cultured
from these three lines of mice revealed a similar pattern of
expression (Figure 6C). In TgNeg and rTgWT neurons, NR1
receptors are clustered in spines as identified by the strong over-
lap between PSD95 and NR1 expression (small arrows in upper
panels of Figure 6C). In contrast, the large arrows in the lower
panels of Figure 6C indicate the reduced colocalization ofNeuron 68, 1067–1081, DePSD95 and NR1 in rTgP301L neurons.
Normalization of NR1 fluorescence inten-
sity in spines to that in the dendritic shafts
demonstrated that the synaptic expres-
sion of NR1 receptors are decreased inrTgP301L mice compared to TgNeg and rTgWT neurons
(***p < 0.001 by Fisher’s PLSD post hoc analysis; Figure 6D).
Our results indicate that tau mislocalization to dendritic spines
damages these spines profoundly by disrupting the synaptic tar-
geting or anchoring of both AMPA and NMDA receptors.
Role of Phosphorylation in htau Mislocalization
We postulated that the mislocalization of tau in spines depends
upon abnormal htau hyperphosphorylation, which occurs to
a greater extent in rTgP301L than rTgWT mice (Figure 7). Tau
consists of at least three structurally distinct regions, including
an amino-terminal projection domain and a carboxyl-terminal
domain that contains repetitive microtubule-binding motifscember 22, 2010 ª2010 Elsevier Inc. 1071
Figure 5. Excitatory Synaptic Transmission
and Surface AMPA Receptors in rTgP301L
and rTgWT Neurons
(A) Representative averaged mEPSCs.
(B) Cumulative frequency distribution of mEPSC
amplitudes. There was a marked shift toward
smaller amplitudes in rTgP301L neurons, and
a slight shift toward smaller amplitudes in rTgWT
neurons (bin size = 1 pA).
(C) Mean mEPSC amplitudes and firing frequen-
cies of the neurons in (A). rTgP301L neurons
exhibited smaller and fewer mEPSCs. n = 15
(TgNeg), 15 (rTgWT), and 14 (rTgP301L) neurons
per group.
(D) PSD95 and surface AMPAR immunoreactivity.
PSD95 (red) detected using a monoclonal anti-
body and surface AMPARs (green) detected using
a polyclonal antibody against the N terminus of
GluR1 (N-GluR1) colocalized in TgNeg and rTgWT
neurons, but rarely in rTgP301L neurons.
(E) Quantification of spine N-GluR1 immunoreac-
tivity colocalizing with PSD95 immunoreactivity,
normalized to N-GluR1 immunoreactivity on adja-
cent dendritic shafts. n = 10 neurons per group.
(F) Density of dendritic spines labeled with
a PSD95 antibody. There were no differences in
the density of PSD95 immunoreactive clusters
along the dendrites. n = 10 neurons per group.
Kolmogorov-Smirnov (B), ANOVA followed by
Fisher’s PLSD post hoc analysis (C, E, and F),
*p < 0.05, ***p < 0.001.
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2004). Hyperphosphorylation of htau at the 14 serine (S) and
threonine (T) residues that can be phosphorylated by proline
(P)-directed S/T kinases has been shown to modulate tau neuro-
toxicity, control tau binding to F-actin and regulate the effect of
htau on the viability of retinal neurons in the fruit fly (Fulga
et al., 2007; Steinhilb et al., 2007a, 2007b). The neurons of fruit
flies, like other lower organisms, lack dendritic spines (Hering
and Sheng, 2001). Therefore, the relevance of this finding to
mammalian neurons, where F-actin concentrates in dendritic
spines, has not been established. To validate that P301L htau
is hyperphosphorylated in vitro on SP/TP residues previously
implicated in tau neurotoxicity, we examined htau phosphoryla-
tion levels in our rat neuron cultures expressing WT or P301L
htau. Changes in tau phosphorylation underlying tau pathology
have a temporally specific sequence (Maurage et al., 2003;
Luna-Mun˜oz et al., 2007; Bertrand et al., 2010) and two of the
earliest changes in tau phosphorylation levels occur at phos-
phoepitopes S199 and T231 (Maurage et al., 2003; Luna-Mun˜oz
et al., 2007; Bertrand et al., 2010). We hypothesize that the
P301L htau-mediated synaptic dysfunction is one of the earliest
signs of tau pathology. Therefore, we compared the phosphory-
lation status of S199 and T231 in rat neurons expressing WT or
P301L htau. Following immunoprecipitation and immunoblotting1072 Neuron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Incof htau from cell lysates prepared from WT or P301L htau-ex-
pressing rat neurons, we found significantly higher levels of
phosphorylated S199 in neurons expressing P301L htau than
in neurons expressing WT htau (Figures 8A and 8B). We also
found a nonsignificant increase in phosphorylated T231 levels
in cultures expressing P301L htau (data not shown). Alz-50,
a marker of advanced changes in pathological conformation
and phosphorylation states of tau could not be detected in
neurons expressing WT or P301L htau (Figure 8A). Taken
together, these results support our hypothesis that tau-mediated
synaptic dysfunction is due, at least in part, to very early changes
in tau phosphorylation. To ascertain further whether proline-
directed phosphorylation controls the mislocalization of htau to
the dendritic spines of mammalian neurons, we changed the
14 SP/TP residues in GFP-tagged WT and P301L htau either to
nonpolar alanine residues to prevent phosphorylation, termed
AP for alanine-proline here, or to negatively charged glutamate
residues to mimic phosphorylation, termed E14 here (Fulga
et al., 2007; Steinhilb et al., 2007a). As in previous experiments,
we measured htau in dendritic spines in rat neurons cotrans-
fected with plasmids encoding DsRed and each of six different
htau proteins (Figure 8C). AP htau and AP/P301L htau accumu-
lated in spines significantly less than even WT htau (***p < 0.001
by Bonferroni post hoc analysis; 5% ± 2%, AP/P301L: 1% ± 1%,.
Figure 6. The P301LHtauMutation Disrupts
Clustering of GluR1, GluR2/3, and NR1
Receptors at Dendritic Spines in Cultured
Mouse Neurons
(A) The PSD95 protein (left column) and the
C terminus of GluR1 subunits (middle; overlay,
right) were costained with a mouse monoclonal
antibody (red) and rabbit polyclonal antibody
(green), respectively. Neurons (21–28 DIV) were
cultured from TgNeg, rTgWT, and rTgP301L
mice (from top to bottom). Note that both surface
and intracellular receptors were detected as all
primary antibodies were added after the fixation
and permeabilization of neurons.
(B) Costaining of PSD95 and GluR2/3 subunits
(detected by an antibody that recognizes the
C termini of both GluR2 and GluR3).
(C) Costaining of PSD95 and NR1 (a mandatory
subunit for functional NMDARs).
(D) Quantification of spine GluR1, GluR2/3, and
NR1 immunoreactivity identified by colocalization
with PSD95 immunoreactivity, normalized to
GluR1, GluR2/3, and NR1 immunoreactivity on
adjacent dendritic shafts, respectively. In all
images, small arrows denote glutamate receptor
clusters that co-localize with PSD95 clusters,
whereas large arrows denote diffuse staining of
glutamate receptors in dendritic shafts. n = 10
neurons per group. ANOVA followed by Fisher’s
PLSD post hoc analysis (D), *p < 0.05, **p < 0.01,
***p < 0.001.
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P301L htau localized to spines more frequently than WT htau
(***p < 0.001 by Bonferroni post hoc analysis; E14: 80% ± 3%,
E14/P301L: 83% ± 3%, WT: 23% ± 5%; Figure 8D).
To ensure that each GFP-htau construct was expressed in
individually transfected hippocampal neurons at an equivalent
level in the primary neuronal cultures, GFP-positive neurons
were separated from untransfected neurons by flow cytometry
(Figure 9). The amount of GFP-tagged WT and mutant htau
was quantified by measuring the fluorescence intensity levels
of isolated GFP-positive cells in suspension. We found equiva-
lent levels of mean GFP fluorescence intensity across all GFP-
htau transfected neuron populations (p = 0.44 by ANOVA;
Figures 9A and 9B). Although flow cytometry provides ameasure
of the expression levels of GFP-htau in the neuronal cell body
and any processes that remained attached through the cellNeuron 68, 1067–1081, Decollection and dissociation procedure,
this method does not selectively measure
htau levels in dendritic shafts. To quantify
GFP-htau expression in dendritic shafts,
we measured fluorescence intensity in
the dendritic shafts and found equivalent
levels of htau in all six transfectants (p =
0.91 by ANOVA; Figure 9C). There were
no significant differences in spine density
among the different transfected neuronal
cultures (data not shown; p = 0.83 by
ANOVA). Taken together, these dataindicate comparable levels of htau expression and no spine
toxicity using all of the GFP-htau variants.
In electrophysiological studies, we confirmed our earlier
observation that significant reductions in the amplitude (***p <
0.001 by Fisher’s PLSD post hoc analysis) and frequency (**p <
0.01 and ***p < 0.001 by Fisher’s PLSD post hoc analysis) of
mEPSCs occur when htau has accumulated in the dendritic
spines (Figures 10A–10D). Collectively, these results demon-
strate that the mislocalization of tau in dendritic spines and
subsequent synaptic dysfunction depend upon proline-directed
phosphorylation of tau.
DISCUSSION
Identification of the earliest neuronal dysfunction associated
with tau-mediated pathologies preceding neurodegeneration iscember 22, 2010 ª2010 Elsevier Inc. 1073
Figure 7. Pathological Tau Species Do Not Accumulate in rTgWT Mice
At 5 months of age (approximately when memory impairments begin, but before neuron loss), immunohistochemical studies revealed that cortical and hippo-
campal neurons in rTgWT mice were rarely immunoreactive for hyperphosphorylated tau species associated with disease. Detection of total tau (human and
mouse) with the Tau-5 antibody in hippocampal and cortical neurons of rTgWT and rTgP301L mice. At 5 months, an immunoreactive signal for tau hyperphos-
phorylated at residue S202 (CP-13) was observed in the cell bodies of a small number of rTgWT hippocampal and cortical neurons. In contrast, CP-13-labeled cell
bodies and neurites were observed in a majority of rTgP301L hippocampal and cortical neurons. Strikingly, positive immunoreactive labeling for tau hyperphos-
phorylated at S409 (PG-5) and S396/S404 (PHF-1) was observed in hippocampal and cortical cell bodies and neurites of 5-month-old rTgP301L, but not rTgWT,
mice. Nuclei were stainedwith DAPI. For each antibody panel, magnification was35 (top row),310 (middle row), and340 (bottom row). Hipp, hippocampus; Ctx,
cortex.
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Aberrant Tau in Spines Impairs Synaptic Functioncritical for understanding the pathophysiology of neurodegener-
ative diseases. An early pathological hallmark of tauopathies is
the abnormal sorting of htau into the somatodendritic compart-
ment of neurons where hyperphosphorylated htau aggregates
(for review, see Avila et al., 2004; Gendron and Petrucelli,
2009). The physiological effects of this missorting are unknown.
Here, we demonstrated that htau is enriched in the PSD of
rTgP301L mice compared to rTgWT mice. Likewise, in primary
neurons expressing P301L or WT htau, mutant tau localized to
dendritic spines more than WT htau does. Together, these
results indicate that htau protein is not only missorted into
dendrites, but also into dendritic spines. The missorted tau
caused early synaptic dysfunction by suppressing AMPAR-
mediated synaptic responses, probably through a global disrup-
tion of postsynaptic targeting or anchoring of glutamate recep-
tors. Our findings confirm, complement and extend a recent
study reporting that htau associates with the PSD complex,
has a role in targeting fyn kinase to postsynaptic compartments
and is involved in coupling NMDARs to PSD95 (Ittner et al.,
2010). Our results go on to demonstrate, for the first time, the
dependence of htau mislocalization to dendritic spines upon
htau hyperphosphorylation, and the deleterious effects that1074 Neuron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Inchtau mislocalization exerts on both AMPARs and NMDARs
(see model in Figure 10E).
The present study demonstrates that tau phosphorylation
plays a critical role in tau mislocalization to dendritic spines.
Phosphorylation is a well-known regulator of tau functions
such as stabilizing microtubules and promoting their assembly
and dynamic stability (reviewed in Avila et al., 2004; Gong
et al., 2005). Here, we showed that the phosphorylation state
of 14 disease-relevant S and T residues also critically regulates
tau mislocalization to dendritic spines and the functional impair-
ments that follow. Changes in the phosphorylation state of
tau disrupt tau-microtubule interactions (reviewed in Avila
et al., 2004; Gendron and Petrucelli, 2009) and, thus, hyperphos-
phorylation might free tau proteins from microtubules in the
dendritic shafts, allowing tau proteins to diffuse to spines
(see model in Figure 10E). Fulga et al. (2007) reported that tau-
induced degeneration results in the accumulation of filamentous
(F) actin, leading to direct interactions between the two proteins.
F-actin is a component of dendritic spines (Fifkova´ and Delay,
1982; Hering and Sheng, 2001), providing another potential
mechanism for hyperphosphorylated tau to mistarget to
dendritic spines. Alternatively, recent studies have found that.
Figure 8. Hyperphosphorylation of P301L
Htau and Effects of Proline-Directed Phos-
phorylation on Tau Accumulation in
Dendritic Spines of Transfected Rat Hippo-
campal Neurons
(A) Levels of phosphorylated htau in rat neurons
expressing WT or P301L htau. Expression of total
htau and phosphorylated S199 (pS199) htau
proteins after immunoprecipitation of total htau
with the Tau-13 antibody from 21–28 DIV primary
rat hippocampal neurons expressing WT or
P301L htau. Changes in tau conformation and
phosphorylation states associated with late tau
pathology were also examined with the Alz-50
antibody. In the middle panel, omission of the
Tau-13 antibody (no Ab) or tissue lysate (no Lys)
revealed no specific immunoblot signal for total
htau.
(B) There wasmore pS199, normalized to total tau,
in the P301L htau-expressing neurons. n = 3
sample preparations.
(C) Images of living rat neurons coexpressing
DsRed and six different GFP-tagged htau proteins
(WT, P301L, AP, AP/P301L, E14, or E14/P301L).
In neurons expressing WT, AP, and AP/301L
htau, most DsRed-labeled spines were devoid of
htau. In neurons expressing P301L, E14, and
E14/P301L htau, most spines contained htau.
(D) Quantification of total spines and htau-contain-
ing spines in neurons coexpressing DsRed and
GFP-tagged htau. A higher percentage of spines
contained htau in neurons expressing P301L,
E14, and E14/P301L htau (compared to WT
htau), and a lower percentage of spines contained
htau in neurons expressing AP and AP/P301L
(compared to WT htau). n = 25–28 neurons per
group. t test (B), ANOVA followed by Bonferroni
post hoc analysis (D), *p < 0.05, ***p < 0.001.
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Aberrant Tau in Spines Impairs Synaptic Functiondynamicmicrotubules can ‘‘invade’’ dendritic spines to influence
spine plasticity (Gu et al., 2008; Hu et al., 2008; Jaworski et al.,
2009), potentially transporting bound tau into the spines.
In our in vitro cell culture models of tauopathy, the phosphor-
ylation-dependent mislocalization of tau into spines was associ-
ated with suppression of basal synaptic function. This suppres-
sion was mediated, at least in part, through a postsynaptic
mechanism involving loss of cell surface AMPARs but before
loss of synapses (see model in Figure 10E). Beyond the impair-
ment in basal excitatory transmission, LTP, a cellular phenom-
enon believed to underlie the synaptic plasticity responsible for
learning and memory, was also inhibited in rTgP301L mice.
These findings complement earlier studies using transgenic
mouse models of tauopathy that express either the FTDP-17
htaumutant P301S orWT htau (Yoshiyama et al., 2007; Polydoro
et al., 2009). In both models, basal synaptic transmission and
LTP were impaired in the hippocampal CA1 region. Importantly,Neuron 68, 1067–1081, Dedeficits in P301S mice occurred before
tangle formation and neuron loss,
emphasizing the importance of under-
standing the role synaptic dysfunction
plays in tau-mediated neurodegeneration(Yoshiyama et al., 2007). Interestingly, Boekhoorn et al. (2006)
reported that young transgenic mice expressing P301L htau
had improved cognitive performance and increased LTP activity
in the dentate gyrus, but not CA1, region of hippocampus. The
authors concluded that tau hyperphosphorylation is essential
for degeneration as this was absent in the young transgenic
mice. Our findings complement and extend these studies by
providing direct evidence that the proline-directed phosphoryla-
tion state of tau is critical for tau-mediated synaptic dysfunction.
Indeed, the AP mutation reversed htau mislocalization and htau-
induced decreases in excitatory synaptic transmission while the
E14 mutation mimicked the deleterious effects of P301L htau.
Our findings do not exclude a role for non-proline-directed S
and T kinases (e.g., microtubule-affinity regulating kinases
[MARKs]) in the phosphorylation-dependent mislocalization of
tau. Taken together, our findings provide an important mecha-
nistic link between phosphorylation-dependent missorting ofcember 22, 2010 ª2010 Elsevier Inc. 1075
Figure 9. Quantitative Measurement of GFP-htau Expression Levels
in Transfected Rat Hippocampal Neurons
(A) Flow cytometry was used to measure GFP fluorescence intensity levels in
hippocampal neurons transfected with WT and mutant GFP-htau. Untrans-
fected hippocampal neurons served as a negative control (left panel, represen-
tative dot blot analysis) and neurons transfected with GFP alone were the posi-
tive control (right panel, representative dot blot analysis). The readout of GFP
fluorescence in the right panel was used to determine the uniform gating
parameters for counting GFP-positive events. Numbers in each quadrant are
the percentage of cells in the respective quadrant. GFP-positive events are
in the lower right quadrant. Dead neurons are in the upper left quadrant, as
identified by increased fluorescence intensity of the DNA marker 7-aminoacti-
nomycin D (7-AAD). Cellular debris is in the lower left and upper right quad-
rants.
(B) Flow cytometry demonstrated that mean GFP fluorescence intensity did
not differ significantly between different populations of hippocampal neurons
transfected with GFP-htau constructs. n = 50,000 events sampled for each
GFP-htau construct (10,000 events/GFP-htau construct x 5 different prepara-
tions).
(C) Fluorescent pixel intensity of GFP-tagged htau constructs in dendritic
shafts. n = 19 neurons per group.
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Aberrant Tau in Spines Impairs Synaptic Functiontau into postsynaptic compartments and the early synaptic
impairments that precede synapse loss (see model in Fig-
ure 10E). Tau-mediated synaptic dysfunction is likely to be
a key step in the transition from the asymptomatic to symptom-
atic phase of tauopathies, the former phase characterized by
changes in functional andmolecular biomarkers, the latter phase
characterized by neuronal death and cognitive deficits.
Our electrophysiological and immunocytochemical experi-
ments revealed that tau mutation or hyperphosphorylation leads
to impaired trafficking or anchoring of AMPARs and NMDARs
that precedes spine loss. Understanding the early pathological
events preceding synapse loss in neurodegenerative diseases
is of critical relevance since synaptic loss correlates more
robustly with cognitive deficits in AD than plaque or tangle load
(Davies et al., 1987; Terry et al., 1991; Masliah et al., 2001;
Selkoe, 2002). Most excitatory synaptic transmission is medi-
ated through dendritic spines which are principal loci of synaptic
plasticity (Hering and Sheng, 2001). Glutamatergic receptors1076 Neuron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Incgovern the morphological plasticity of spines with NMDARs
regulating the formation of new spines and AMPARs stabilizing
established spines (Fischer et al., 2000). Interestingly, a recent
study demonstrated that tau decreased NMDAR expression in
the PSD complex, though no alterations in NMDAR-mediated
currents were detected (Ittner et al., 2010). Our study comple-
ments and extends these findings to include tau-induced impair-
ments in synaptic targeting or anchoring of AMPARs and
AMPAR-mediated synaptic currents. Dendritic spine stability is
compromised by loss of synaptic AMPARs, leading to spine
loss (McKinney et al., 1999; Richards et al., 2005; for review,
see McKinney, 2010). Despite the strong correlation between
loss of spines and synaptic AMPARs, the temporal relationship
between these two physiological events is not well-defined.
It has also been reported that these two cellular processes can
be dissociated (Sdrulla and Linden, 2007; Wang et al., 2007).
Although other studies (Shahani et al., 2006; Tackenberg and
Brandt, 2009) have also failed to observe tau-mediated spine
loss, the state of synaptic AMPARs was not reported in these
papers. Thus, we hypothesize that the absence of spine loss,
despite decreased synaptic AMPARs, is due to the very early
nature of the tau-induced synaptic impairments. A similar theory
was proposed in a study using the APPswe/PS1 dE9 transgenic
mouse model of AD (Shemer et al., 2006). The relationship
between Ab-induced early synaptic dysfunction and tau-medi-
ated global disruption of glutamate receptors remains to be
determined. A recent report (Zempel et al., 2010) suggests that
spines might serve as a site of convergence for amyloid beta
and tau. The authors found that various cell stressors and
amyloid beta oligomers induce the missorting of cytoskeletal
proteins, including hyperphosphorylated tau, into the somato-
dendritic region which was correlated with the rapid loss of
spines (%6 hr). The present study further extends the Zempel
et al. study by showing that phosphorylated tau proteins not
only traffic to somatodendritic regions, but also aberrantly enter
into dendritic spines, causing synaptic dysfunction by impeding
synaptic recruitment of AMPA and NMDA receptors.
In conclusion, these findings capture what is likely the earliest
synaptic dysfunction that precedes synapse loss in tauopathies
and provide an important mechanistic link between proline-
directed tau phosphorylation and the mislocalization of tau to
dendritic spines. Our selective approach (see model in Fig-
ure 10E) to studying structurally intact mammalian neurons
in vivo and in vitro revealed three results unobtainable from non-
mammalian studies: (1) soluble forms of the microtubule-associ-
ated protein tau accumulate in dendritic spines, a neuronal
compartment that is devoid of stable microtubules but rich in
F-actin; (2) the hyperphosphorylation of tau at sites governing
F-actin binding in aspiny Drosophila neurons directs tau to post-
synaptic compartments in spiny mammalian neurons; and (3) the
accumulation of tau in spines disturbs AMPAR and NMDAR traf-
ficking or anchoring to the PSD. Our growing appreciation for the
effects of other dementia-related proteins on dendritic spines
(Davies et al., 1987; Selkoe, 2002; Hsieh et al., 2006; Kramer
and Schulz-Schaeffer, 2007; Fuhrmann et al., 2007; Knobloch
and Mansuy, 2008; Smith et al., 2009) highlights the importance
of dendritic spines as a locus in which to study the nexus of inter-
actions involving tau. Understanding these interactions prior to.
Figure 10. Effects of Proline-DirectedPhos-
phorylation of Tau on Excitatory Synaptic
Transmission in Transfected Rat Hippo-
campal Neurons and a Hypothetical Model
of Tau-Mediated Synaptic Dysfunction
Preceding Neurodegeneration
(A) Representative averaged mEPSCs.
(B) The cumulative frequency distribution of
mEPSC amplitudes of neurons in (A). There was
a shift toward smaller amplitudes in neurons ex-
pressing P301L, E14, and E14/P301L htau.
(C) Mean mEPSC amplitudes and (D) frequencies
of the neurons in (A). Neurons expressing P301L,
E14, and E14/P301L htau exhibited smaller and
fewer mEPSCs. n = 14 (WT), 16 (P301L), 15 (AP),
15 (AP/P301L), 15 (E14), and 15 (E14/P301L)
neurons per group.
(E) A diagram describing the hypothetical cellular
processes underlying how hyperphosphorylated
tau impairs excitatory synaptic transmission
through a loss of functional surface glutamate
receptors. Since Ab and genetic mutations in tau
induce hyperphosphorylation of tau, we hypothe-
size that, following tau hyperphosphorylation, tau
dissociates from the microtubules and is aber-
rantly targeted to dendritic spines, possibly
through an actin-based process. Once mislocal-
ized to the spines, tau impairs glutamatergic
synaptic transmission by reducing the number of
functional AMPA and NMDA receptors on the
surface of the neuronal membrane through
impaired anchoring of the glutamate receptors to
the PSD complex, decreased exocytosis or
increased endocytosis of the receptors. ANOVA
followed by Fisher’s PLSD post hoc analysis (C
and D), Kolmogorov-Smirnov (B), **p < 0.01,
***p < 0.001.
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Aberrant Tau in Spines Impairs Synaptic Functionthe occurrence of neuronal loss will become increasingly impor-
tant as preventive strategies shift the timing of interventions to
pre-degenerative phases of disease. The aberrant mislocaliza-
tion of tau proteins in dendritic spines might be a target in these
strategies.
EXPERIMENTAL PROCEDURES
Materials
All chemical reagents and cell culture supplies were purchased from Sigma,
Thermo-Fisher Scientific, or GIBCO/Invitrogen unless otherwise indicated.
Antibodies used were Tau-13 (Covance, Princeton, NJ), polyclonal PSD95
(clone c-20; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), monoclonal
PSD95 (Chemicon, Billerica, MA), a-tubulin (Sigma), and Tau-5 and phosphor-
ylated S199 and T231 (Invitrogen). The polyclonal antibody against the
N terminus of GluR1 subunits of AMPARs (N-GluR1), the rabbit polyclonal
antibodies against the C terminus of GluR1 or 2/3 subunits of AMPARs and
the NR1 antibody were generous gifts from Dr. Richard Huganir at the Johns
Hopkins University Medical School. The Alz-50, CP-13, PG-5, and PHF-1 anti-
bodies were generous gifts from Dr. Peter Davies at Albert Einstein College of
Medicine.
Animals
Briefly, our methods for generating rTg4510 mice have been described in
detail (Santacruz et al., 2005). We generated rTg21221 mice expressing WTNehtau in a similar manner. To achieve regulatable expression, we utilized
a system of responder and activator transgenes. Mice expressing the acti-
vator transgenes were a generous gift of Dr. Eric Kandel at Columbia Univer-
sity, and were successively backcrossed at least five times onto a 129S6
background strain. Responder mice were maintained in the FVB/N back-
ground strain. The WT htau cDNA encoding human 4-repeat tau lacking the
amino-terminal sequences (4R0N) was modified such that the WT htau trans-
gene (containing exons 1, 4 and 5, 7, 9–13, intron 13, and exon 14) driven by
TRE was placed in the context of the mouse prion protein gene (prnp) tran-
scribed but untranslated sequences, which were derived from the MoPrP.Xho
expression vector. First, the SalI fragment of a previously created WT htau
transgene, including the whole htau coding sequence, was inserted into the
unique XhoI site of MoPrP.Xho to generate prnp.WT htau. Next, the XbaI frag-
ment of prnp.WT htau, including partial sequences of prnp introns 1 and 2,
along with exons 2 and 3, and the WT htau open reading frame, was cloned
into the unique XbaI site in the inducible expression vector pTRE (Clontech,
Inc., Cambridge, UK), resulting in the plasmid, pTRE.prnp.WT htau. The resul-
tant DNA was digested with XhoI and NgoM IV enzymes, fractionated, and
purified by electroelution followed by organic extraction. Purified fragments
containing a modified htau transgene were introduced by microinjection
into the pronuclei of donor FVB/N embryos by standard techniques. All
experiments with animals described in this study were conducted in full
accordance with the American Association for the Accreditation of Laboratory
Animal Care and Institutional Animal Care and Use Committee at the
University of Minnesota. Every effort was made to minimize the number of
animals used.uron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Inc. 1077
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All htau constructs were taggedwith enhancedGFP (referred to as GFP) on the
N terminus and expressed in the pRK5 vector and driven by a cytomegalovirus
(CMV) promoter (Clontech, Inc.). The GFP and DsRed constructs (Clontech,
Inc.) were also expressed in the pRK5 vector and driven by a CMV promoter.
The WT htau construct encoded human four-repeat tau lacking the N-terminal
sequences (4R0N) and contained exons 1, 4 and 5, 7, and 9–13, intron 13, and
exon 14. The P301L htau construct was generated from the 4R0N WT htau
sequence by mutating the proline to leucine at residue 301 with a QuikChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA). Using WT htau as
a template, two htau constructs termed AP or E14 were generated bymutating
all 14 S/P or T/P amino acid residues (T111, T153, T175, T181, S199, S202,
T205, T212, T217, T231, S235, S396, S404, and S422; numbering based on
the longest 441-amino acid brain isoform of htau) to alanine (AP) or glutamate
(E14). The AP/P301L or E14/P301L htau construct was generated by mutating
the proline to leucine at residue 301 in AP or E14 htau, respectively. The PCR-
mediated site-directed mutagenesis was confirmed by sequencing.
Neuronal Rat Cultures and Transfections
Based on methods described in Lin et al. (2004), dissociated rat hippocampal
primary neuron cultures were prepared. Briefly, a 25mmglass coverslip (thick-
ness, 0.08 mm) was glued over a 22 mm hole in the bottom of a 35 mm tissue-
culture dish using silicone sealant. Dissociated neuronal cultures from rat
hippocampi at P1 and P2 were prepared. Neurons were plated onto prepared
35 mm tissue culture dishes at a density of 1 3 106 cells per dish. The age of
cultured neurons was counted from the day of plating (1 DIV). Neurons at 7–10
DIV were transfected using a standard calcium phosphate precipitation
method and allowed to grow to maturity (>3 weeks) to be imaged. Neurons
were transfected with equivalent concentrations of plasmids encoding one
of six different GFP-tagged htau constructs (WT, P301L, AP, AP/P301L,
E14, or E14/P301L htau). Neurons transfected with htau constructs were
cotransfected with DsRed to visualize dendritic spines. Some neurons were
transfected with GFP alone to visualize dendritic spines. The culture dishes
fit tightly in a homemade holding chamber on a fixed platform above an in-
verted epifluorescent microscope sitting on an X–Y translation stage (Burleigh
Instruments, Fishers, NY).
Neuronal Mouse Cultures
Following the protocol described in Strasser et al. (2004), hippocampal and
glial cultures were prepared from E16 and P1–2 mice, respectively. Glial
cultures prepared from P1–2 mouse cortices were plated on tissue culture
dishes in glial plating media (minimal essential medium [MEM] with Earle’s
salts, 10% fetal bovine serum [FBS] or newborn calf serum, 2 mM glutamine,
10 mM sodium pyruvate, 10 mM HEPES, 0.6% glucose, 100 U/ml penicillin
and 100 mg/ml streptomyocin). For primary hippocampal neuron cultures,
approximately 1.5 3 104 cells were plated on sets of 5 3 12 mm coverslips
that had been previously coated with Poly-D-Lysine (100 mg/ml) + laminin
(4 mg/ml) in neuronal plating media (MEM with Earle’s salts, 10 mM HEPES,
10 mM sodium pyruvate, 0.5 mM glutamine, 12.5 mM glutamate, 10% FBS,
and 0.6% glucose). Each set of 5 coverslips was maintained in a 35 mm
dish and each dish corresponded to 1mouse. Approximately 4 hr after plating,
the media was replaced with either neuronal growth medium (Neurobasal
media with B27 supplement, 0.5 mM glutamine) that had been conditioned
on glia for 24–48 hr immediately prior to use. Mice were genotyped by PCR
analysis of tail snip lysates using transgene-specific primers.
Electrophysiology
Miniature EPSCs were recorded from cultured dissociated rat and mouse
hippocampal neurons at 22–30 DIV with a glass pipette (resistance of
5 MU) at holding potentials of 55 mV and filtered at 1 kHz as previously
described (Liao et al., 2005). Input and series resistances were checked before
and after the recording of mEPSCs, which lasted 5–20 min. There were no
significant difference in the series resistances and input resistance among
various groups of experiments. One recording sweep lasting 200 ms was
sampled for every 1 s. Neurons were bathed in artificial cerebrospinal fluid
(ACSF) at room temperature (25C) with 100 mM APV (an NMDAR antagonist),
1 mMTTX (a sodium channel blocker), and 100 mMpicrotoxin (GABAa receptor1078 Neuron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Incantagonist), gassed with 95%O2–5%CO2. For experiments using rat cultures,
the ACSF contained (in mM) 119 NaCl, 2.5 KCl, 5.0 CaCl2, 2.5 MgCl2,
26.2 NaHCO3, 1 NaH2PO4, and 11 glucose. The frequency of mEPSCs
recorded in our cultured mouse neurons is very high and, therefore, these
neurons were bathed in ACSF with 0.5 mM CaCl2 in order to decrease the
overlap of individual mEPSC responses. The internal solution in the patch
pipette contained (in mM) 100 cesium gluconate, 0.2 EGTA, 0.5 MgCl2,
2 ATP, 0.3 GTP, and 40HEPES (pH 7.2with CsOH). All mEPSCswere analyzed
with the MiniAnalysis program designed by Synaptosoft Inc. Detection crite-
rion for mEPSCs was set as the peak amplitude 3 pA. Each mEPSC event
was visually inspected and only events with a distinctly fast-rising phase and
a slow-decaying phase were accepted. The frequency and amplitude of all
accepted mEPSCs were directly read out using the analysis function in the
MiniAnalysis program. The averaged parameters from each neuron were
treated as single samples in any further statistical analyses.
For extracellular recordings of field excitatory postsynaptic potentials
(fEPSPs), hippocampal slices (350–400 mm) were prepared from 1.3- and
4.5-month old TgNeg and rTgP301L mice following standard procedures.
In the recording chamber, slices were constantly perfused with ACSF solution
containing (in mM) 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 2 CaCl2,
1 MgCl2, and 10 dextrose, at near physiological temperature 30
C–31C.
For field recordings, a glass pipette with resistance of 1–2 MU when filled
with ACSF was placed in striatum radiatum of CA1, and a tungsten bipolar
electrode was positioned to stimulate the Schaffer-collateral pathway. LTP
was induced with a theta burst protocol in which 5 fEPSPs were evoked at
100 Hz to form a burst and the burst was repeated at 5 Hz.Flow Cytometry
Flow cytometry was used to measure the levels of GFP-htau protein expres-
sion in individually transfected neurons by quantifying the GFP fluorescence
intensity of cells in suspension. Three-week-old rat neuron cultures expressing
GFP-htau (WT, P301L, AP, AP/P301L, E14, E14/P301L) were washed with 13
phosphate-buffered saline (PBS) and treated with trypsin/EDTA (Sigma) for
6 min at 25C with gentle shaking to create a single-cell suspension. Cells
were scraped, collected, and gently triturated before addition of MEM contain-
ing 10% FBS and 2 mM glutamine to inactivate the trypsin. Cell suspensions
were centrifuged for 3 min at 1000 3 g, resuspended in 13 PBS containing
2% FBS, filtered with a 5 ml polystyrene round bottom tube with a cell strainer
cap (Becton Dickinson, San Jose, CA) and stored at 4C until flow cytometry
analysis. Flow cytometry/sorting was done on a FACSVantage DIVA SE
(Becton Dickinson) flow cytometer using Diva software (version 5.0.2). The
fluorescent DNA marker 7-aminoactinomycin D (7-AAD; 1:500; Invitrogen)
was used to isolate live cells. The flow cytometry data were analyzed and
scatter profiles for fluorescence intensities plotted using Flowjo software
(Treestar, Ashland, OR, version 8.8.6).Tau Immunoprecipitation
Three-week-old rat neuron cultures expressing GFP-htau (WT, P301L, AP,
AP/P301L, E14, E14/P301L) were lysed (50 mM Tris-HCl, 150 mM NaCl,
1 mM EDTA, 1.5% Triton X-100, 0.1% Na deoxycholate, phosphatase inhibi-
tors [phenylmethylsulfonyl fluoride, phenenthroline monohydrate, and phos-
phatase inhibitor cocktails I and II; 1:1000, Sigma] and protease inhibitor cock-
tail [1:100; Sigma]; 30 min at 4C on shaker), scraped and lysates were
collected for determination of total protein concentration by the BCA protein
assay. An aliquot of each sample (450 mg) was diluted in 1 ml of dilution buffer
(50 mM Tris-HCl, 150 mMNaCl [pH 7.4] and freshly added protease and phos-
phatase inhibitors) and immunodepleted with 150 ml protein A and 150 ml
protein G for 1 hr at 4C. Immunodepleted samples were incubated with 30
mg Tau-13 antibody and 100 ml protein G Sepharose beads overnight at 4C.
The next day, beads were washed with buffer A (50 mM Tris-HCl, 0.1% Triton
X-100, 300 mM NaCl, 1 mM EDTA) for 20 min at 4C followed by a wash with
buffer B (50 mM Tris-HCl, 0.1% Triton X-100, 150 mM NaCl, 1 mM EDTA) for
20 min at 4C. Sample was eluted off the beads using 1X sodium dodecyl
sulfate (SDS) loading buffer, heated to 95C for 10 min and analyzed by
western blot analysis as described using the Tau-13 (total tau), pS199,
pT231, and Alz-50 antibodies..
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Preparation of postsynaptic densities from mouse brains was performed
based on the procedures of Cheng et al. (2006). Briefly, PSD fractions were
prepared from mouse forebrains at 4C. Forebrains were collected from adult
mice and homogenized in ice-cold Buffer A (6 mM Tris [pH 8.0], 0.32 M
sucrose, 1 mM MgCl2, 0.5 mM CaCl2, phosphatase inhibitors [phenylmethyl-
sulfonyl fluoride, phenenthroline monohydrate, and phosphatase inhibitor
cocktails I and II; 1:100, Sigma] and protease inhibitor cocktail [1:100; Sigma]).
The resulting extract was centrifuged at low speed (1400 3 g for 10 min) to
collect the first supernatant (S1). The pellet (P1) was re-extracted and homog-
enized with buffer A and centrifuged at 710 3 g for 10 min. This supernatant
(S10) was pooled with the S1 supernatant and then centrifuged at 710 3 g
for 10 min. Then, the supernatant was removed and centrifuged at 13,800 3
g for 12 min to isolate the S2 supernatant used for western blotting. The S2
fraction contains both pre- and postsynaptic proteins. The pellet (P2) was
resuspended and homogenized in Buffer B (0.32 M sucrose and 6 mM Tris
[pH 8.0] with the same phosphatase and protease inhibitors). This homogenate
was loaded onto a discontinuous sucrose gradient (0.85/1/1.15M in 6 mM Tris
[pH 8.0]), and centrifuged at 82,500 3 g for 2 hr. The synaptosome fraction
(Syn) between 1 M and 1.15 M sucrose was collected and adjusted to 2 ml
with buffer B. An equal volume of buffer C (12 mM Tris [pH 8.0] and 1%
Triton X-100) was added, mixed for 15 min, and centrifuged at 32,800 3 g
for 20 min. The PSD protein pellet (PSD-1) was resuspended in 40 mM Tris
(pH 8.0). The protein concentration was determined by Pierce BCA protein
assay using bovine serum albumin as standard. For western blot detection
of proteins of interest in the S2 and PSD-1 fractions of mouse forebrains,
protein-corrected (BCA assay) samples were diluted in reducing sample
buffer, electrophoresed on 10% Tris-HCl gels (Bio-Rad, Hercules, CA), and
transferred onto 0.45 mm polyvinylidene difluoride membranes (Millipore,
Billerica, MA). Briefly, blots were processed with the primary antibody
(Tau-13, a-tubulin, or polyclonal PSD95) and visualized using enhanced chem-
iluminescence reagents (Pierce, Rockford, IL), followed by exposure onto
Kodak hyperfilm. Band density from film exposed within the linear range
was measured using OptiQuant 3.0 software (Packard Instrument Co.,
Downers Grove, IL).
Immunohistochemistry
Immunohistochemical detection of total and phosphorylated tau species in
transgenic and control mice was performed as previously described (Rams-
den et al., 2005). Briefly, hemibrains were immersion fixed in 10% formalin
for 24–48 hr and embedded in paraffin. Serial sections were cut at 5 mm using
a microtome, mounted onto CapGap slides (Thermo-Fisher), and rehydrated
according to standard protocols.Mounted slideswere pretreatedwith a citrate
buffer (pH 6.0) in a Black & Decker (Owings, MD) steamer for 30 min, with
a 10 min cool down. Standard 2 day immunostaining procedures using perox-
idase-labeled streptavidin and DAB chromagen on an automated TechMate
500 capillary gap immunostainer (Ventana Medical Systems, Tucson, AZ)
were used with antibodies directed against total human and mouse tau
(Tau-5) or human tau hyperphosphorylated at S202, S396/S404, and S409
(CP-13, PHF-1, PG-5 respectively). Photomicrographs of hippocampal and
cortical neurons were captured at three different magnifications (35, 310,
and 340) with a Zeiss Axioskop microscope coupled to a CCD camera and
processed and assembled in Adobe Photoshop.
Immunolabeling Glutamate Receptors and PSD95
As previously described (Liao et al., 1999), a green fluorescent dye-conjugated
rabbit polyclonal antibody against the N terminus of GluR1 subunits of AM-
PARs was added to culture media of living mouse neurons at a concentration
of 1:100 to label surface AMPARs. Neurons were incubated with the antibody-
containing media for 1 hr at 37C and were subsequently fixed and permeabi-
lized successively with 4% paraformaldehyde/4% sucrose in 13 PBS (25C,
20 min), –20C 100% methanol (4C, 10 min), and 0.2% Triton X-100 (25C,
10–20min). The neuronswere then incubatedwith amouse anti-PSD95mono-
clonal antibody (1:100) in 10% donkey serum at 4C overnight. The PSD95
protein is a widely-used marker of dendritic spines, because it is highly en-
riched in postsynaptic densities. Immunocytochemical detection of total
GluR1 and 2/3 AMPAR subunits with two separate C terminus antibodiesNeand NR1with a N terminus antibody was performed in a similar manner except
that all primary antibodies were added after the fixation and permeabilization
of the neurons and, therefore, both surface and intracellular receptors were
labeled (Figure 6). Primary antibodies were visualized with the appropriate
secondary antibodies conjugated to either FITC or rhodamine (Jackson Immu-
noresearch Laboratories, West Grove, PA).
Image Analysis of Fixed and Living Neurons
Coverslips of fixed mouse neurons or rat neurons cotransfected with various
GFP-tagged tau constructs and DsRed (or GFP alone) were photographed
on an inverted Nikon epifluorescent microscope with a 603 oil lens and
a computerized focus motor at 21–35 DIV. All digital images were photo-
graphed and processed with MetaMorph Imaging System (Universal Imaging
Corporation, West Chester, PA). All images of fixed and live neurons were
taken as stacks (15 planes at 0.5micron increments) and processed by decon-
volution analyses using the MetaMorph software with the nearest planes and
averaged into one single image. A dendritic protrusion with an expanded head
that was 50%wider than its neckwas defined as a spine. The number of spines
from one neuron was counted manually and normalized per 100 mm dendritic
length. To measure the dendritic fluorescence intensity of individual rat hippo-
campal neurons, living neurons were photographed and processed withMeta-
Morph software as described above. Then, using Image J software (Image
J 1.42q Software, National Institutes of Health, http://rsb.info.nih.gov/ij), the
fluorescent pixel intensity along a user-defined line drawn at three different
random positions across a GFP htau-transfected dendrite was measured as
distance along the x axis plotted against pixel gray value on the y axis and
expressed as area under a curve. The area under the curve above baseline
was measured and represented as fluorescent pixel intensity using Image J
software. To estimate the amount of glutamate receptors in dendritic spines,
fixed mouse neurons immunoreactive for PSD95 and a GluR antibody
(N-GluR1, GluR1 detected with a C terminus antibody, GluR2/3, NR1) were
photographed and processed with MetaMorph software as described above.
Then, immunoreactive clusters of PSD95 were autoselected using the Meta-
Morph software and the location of these clusters was transferred to images
displaying glutamate receptor immunoreactivity on the same neuron. PSD95
immunoreactivity was used to identify dendritic spines. A cursor was placed
in the center of the glutamate receptor clusters in dendritic spines to estimate
glutamate receptor immunoreactivity as fluorescent pixel intensity in the
spines (value Y1). Another cursor was placed in an adjacent dendritic shaft
to measure glutamate receptor fluorescent pixel intensity (value Y2) and the
ratio of glutamate receptor immunoreactive fluorescence intensity in spines/
dendrites (Y1/Y2) was plotted on the y axis.
Behavioral Testing
Spatial reference memory was measured using the Morris water maze with
a protocol tailored for the rapid learning of the 129FVBF1 mice (Westerman
et al., 2002; Ramsden et al., 2005). Mice were prehandled for 10 days during
the 2 weeks preceding Morris water maze testing. Prehandling consisted of
a 20 s exposure to water at a depth of 1 cm and was designed to acclimatize
the mice to the introduction and removal from the testing pool. At each age
tested, mice received visible platform training for three days, six trials per
day, followed by hidden platform training for six days, four trials per day.
Four probe trials of 30 s duration were performed 20 hr after eight, 12, 16,
and 24 hidden training trials. The mean platform crossing index of all four
probes was calculated. All trials weremonitored using a computerized tracking
system (Noldus EthoVision 3.0; Noldus Information Technology, Wageningen,
The Netherlands), and performance measures were extracted using Wintrack
(Wolfer et al., 2001).
Statistical Analyses
Statistical analysis utilized Student’s t tests, analysis of variance (ANOVA) and
repeated-measures ANOVA. Post hoc comparisons were performed using
Fisher’s PLSD or Bonferroni correction to compare the difference between
the means of experimental groups. The Kolmogorov-Smirnov test was used
to examine the difference between cumulative frequency distributions in the
electrophysiological experiments. Repeated-measures ANOVA was used to
examine differences in spatial reference memory performance and transgenicuron 68, 1067–1081, December 22, 2010 ª2010 Elsevier Inc. 1079
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Aberrant Tau in Spines Impairs Synaptic Functionstatus served as the between-subject variable, while training block served as
the within-subject variable. Statistical significance is p < 0.05. All data are ex-
pressed as mean ± SEM.
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